org placeholder image

Douglas Girgenti

Vice President of Drug Development at Melinta Therapeutics

  • LinkedIn

Clinical expertise in pediatric and adult medicine and surgery, and a record of excellence as Clinician and Global Clinical Program Lead in all Phases of clinical pediatric and adult, com...

Read More

map
MELINTA THERAPEUTICS

MELINTA THERAPEUTICS

  • description Description
    High touch and big impact are trademarks of Melinta. We are nimble and agile without sacrificing our dedication to adding value everywhere we go. You see, the people of Melinta are believers....

    Read More

  • Employees count Employees 51-200
  • Revenue Revenue 50 Million to 100 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Melinta Therapeutics Org Chart and Mapping

Employees

David Molstad

Preclinical Staff Scientist

Kajal Preuss

Director of Brand Marketing

Jennifer Sanfilippo

General Counsel & Chief Compliance Officer

Sandra McCurdy

Field Microbiology Affairs Director

Mahesh Kulkarni

Senior Director, Pharmaceutical Development & Technical Operations

Barry Turner

Director, External Supply & Project Management at Melinta Therapeutics

Tim Brady

Regional Sales Director - West

Frequently Asked Questions Regarding Douglas Girgenti

Answer: Douglas Girgenti works for Melinta Therapeutics as Vice President of Drug Development

Answer: Douglas Girgenti’s role in Melinta Therapeutics is Vice President of Drug Development

Answer: Douglas Girgenti's email address is d***@gmail.com

Answer: Douglas Girgenti's business email address is d****@boehringer-ingelheim.com

Answer: Douglas Girgenti’s direct phone number is (***)-***-****

Answer: Douglas Girgenti works in the industry of: Biotechnology

Answer: Douglas Girgenti is the current Vice President of Drug Development at Melinta Therapeutics.... Read More

Answer: Douglas Girgenti works Melinta Therapeutics located at 44 Whippany Rd Ste 280, Parsippany, New Jersey, 07960, United States

Answer: Melinta Therapeutics's Vice President of Drug Development is Douglas Girgenti

Answer: Douglas Girgenti contact details:

  • Phone number  :  (***)-***-****
  • Email  :  d****@boehringer-ingelheim.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access